PINS Stimulator System for Patients With Treatment Resistant Depression
Primary Purpose
Treatment-Resistant Depression
Status
Unknown status
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Deep Brain Stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Treatment-Resistant Depression
Eligibility Criteria
Inclusion Criteria:
- Subject is aged ages 20-70 years
- Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by DSM-IV-TR criteria
- First episode onset before age 45
- Current episode > 12 months duration
- In the current episode: Documented resistance (i.e. persistence of the major depressive episode) to a minimum of 4 adequate depression treatments from at least 3 different treatment categories (e.g. SSRI's)
- SNRI's, TCA's, MAO-inhibitors, Mirtazipine, Nefazodone, Trazodone, Bupropion, lithium augmentation, thyroid augmentation, ECT); Adequacy of treatments as defined by a score of at least 3 according to the amended Antidepressant Treatment History Form (ATHF) criteria
- Hamilton Depression Rating Scale (HDRS) of > 20 at 3 separate baseline visits, rated by 2 separate psychiatrists, Baseline 2 and Baseline 3 HDRS scores cannot improve ≥ 25%
Exclusion Criteria:
- Patients with hearing impairment
- Failures of important organs and in severe conditions
- Be reluctant or disabled to receive neuropsychological assessments;
- Participate in other clinical trial
- Has a life expectancy of < 1 year
- The investigator and/or enrollment review committee, would preclude participation in the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Deep Brain Stimulation
Placebo
Arm Description
Stimulation is on
Stimulation is off
Outcomes
Primary Outcome Measures
Changes in the Hamilton Depression Rating Scale-17
Secondary Outcome Measures
The incidence of all adverse events
Full Information
NCT ID
NCT02253355
First Posted
September 27, 2014
Last Updated
October 13, 2016
Sponsor
Beijing Pins Medical Co., Ltd
Collaborators
Beijing Tiantan Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02253355
Brief Title
PINS Stimulator System for Patients With Treatment Resistant Depression
Official Title
PINS Stimulator System for Patients With Treatment Resistant Depression
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
December 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Beijing Pins Medical Co., Ltd
Collaborators
Beijing Tiantan Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Evaluate the effects and safety of Deep Brain Stimulation (DBS) to treat on patients with Treatment-Resistant Depression (TRD) and using functional magnetic resonance imaging (fMRI)to evaluate the influence of acupuncture on patients, which will be afford objective evidence for the mechanism of Acupuncture on depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Treatment-Resistant Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Deep Brain Stimulation
Arm Type
Experimental
Arm Description
Stimulation is on
Arm Title
Placebo
Arm Type
Sham Comparator
Arm Description
Stimulation is off
Intervention Type
Device
Intervention Name(s)
Deep Brain Stimulation
Other Intervention Name(s)
PINS Stimulator System
Primary Outcome Measure Information:
Title
Changes in the Hamilton Depression Rating Scale-17
Time Frame
1, 3, 6 and 12 months of stimulation
Secondary Outcome Measure Information:
Title
The incidence of all adverse events
Time Frame
1, 3, 6 and 12 months of stimulation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject is aged ages 20-70 years
Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by DSM-IV-TR criteria
First episode onset before age 45
Current episode > 12 months duration
In the current episode: Documented resistance (i.e. persistence of the major depressive episode) to a minimum of 4 adequate depression treatments from at least 3 different treatment categories (e.g. SSRI's)
SNRI's, TCA's, MAO-inhibitors, Mirtazipine, Nefazodone, Trazodone, Bupropion, lithium augmentation, thyroid augmentation, ECT); Adequacy of treatments as defined by a score of at least 3 according to the amended Antidepressant Treatment History Form (ATHF) criteria
Hamilton Depression Rating Scale (HDRS) of > 20 at 3 separate baseline visits, rated by 2 separate psychiatrists, Baseline 2 and Baseline 3 HDRS scores cannot improve ≥ 25%
Exclusion Criteria:
Patients with hearing impairment
Failures of important organs and in severe conditions
Be reluctant or disabled to receive neuropsychological assessments;
Participate in other clinical trial
Has a life expectancy of < 1 year
The investigator and/or enrollment review committee, would preclude participation in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jia Fumin, PhD
Phone
+86 010-59361265
Email
pins_medical@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Li Luming, PhD
Organizational Affiliation
Tsinghua University
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
PINS Stimulator System for Patients With Treatment Resistant Depression
We'll reach out to this number within 24 hrs